<DOC>
<DOCNO>
EP-0002263
</DOCNO>
<TEXT>
<DATE>
19790613
</DATE>
<IPC-CLASSIFICATIONS>
C07D-211/00 A61K-31/451 A61K-31/645 A61P-25/00 C07D-211/70 C07D-211/22 A61P-25/18 A61K-31/445 <main>C07D-211/70</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
3-trifluoromethylsulfinyl analogs of cyproheptadine, process for their preparation and pharmaceutical composition thereof.
</TITLE>
<APPLICANT>
merck & co incus<sep>merck & co. inc.<sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us<sep>merck & co. inc.<sep>
</APPLICANT>
<INVENTOR>
remy david carroll<sep>remy, david carroll<sep>remy, david carroll607 jenkins laneus-19454 north wales, pennsylvaniaus<sep>remy, david carroll<sep>remy, david carroll607 jenkins laneus-19454 north wales, pennsylvaniaus<sep>
</INVENTOR>
<ABSTRACT>
cyproheptadine derivatives of formula:    or pharmaceutically acceptable salt thereof,  wherein:   r represents (1) lower alkyl of 1-3 carbons, especially -ch₃,    -ch₂ch₂oh; and   r¹ represents hydrogen, lower alkyl of 1-3 carbon atoms, or  fluoro,   are antipsychotic agents, with a low propensity to induce  extrapyramidal side effects that are experienced with most  major tranquilizers.  compounds (1) are generally prepared by treatment of  the intermediate 5-carbinol with a dehydrating reagent, or by  alkylation of the piperidine nitrogen with the appropriate  alkyl or substituted alkyl group.  
</ABSTRACT>
</TEXT>
</DOC>
